Mon, 10 Dec 2018 05:33:23 GMT
Roche executive O'Day to become new Gilead Sciences CEO
The drugmaker Gilead Sciences is set to appoint Daniel O'Day, the executive of Roche Holding AG, as the company's new CEO with the official announcement expected to be made on Monday.